DNA hypermethylation of CADM1, PAX5, WT1, RARβ, and PAX6 genes in oropharyngeal cancer associated with human papillomavirus
Language English Country United States Media print-electronic
Document type Journal Article, Research Support, Non-U.S. Gov't
PubMed
34974810
PubMed Central
PMC9624252
DOI
10.1080/15592294.2021.2018812
Knihovny.cz E-resources
- Keywords
- Biomarker, DNA methylation, epigenetics, head and neck cancer, human papillomavirus, oropharyngeal cancer,
- MeSH
- PAX5 Transcription Factor genetics MeSH
- Alphapapillomavirus * MeSH
- Cell Adhesion Molecule-1 genetics metabolism MeSH
- Squamous Cell Carcinoma of Head and Neck genetics MeSH
- DNA metabolism MeSH
- Papillomavirus Infections * complications MeSH
- Humans MeSH
- DNA Methylation MeSH
- Head and Neck Neoplasms * genetics MeSH
- Oropharyngeal Neoplasms * pathology MeSH
- Papillomaviridae MeSH
- Prognosis MeSH
- WT1 Proteins genetics metabolism MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Names of Substances
- PAX5 Transcription Factor MeSH
- Cell Adhesion Molecule-1 MeSH
- CADM1 protein, human MeSH Browser
- DNA MeSH
- PAX5 protein, human MeSH Browser
- PAX6 protein, human MeSH Browser
- WT1 Proteins MeSH
- retinoic acid receptor beta MeSH Browser
- WT1 protein, human MeSH Browser
Recently, an increasing incidence of HPV-induced oropharyngeal squamous cell carcinoma (OPSCC) has been observed. Moreover, locoregionally advanced stages require a combined modal approach, and the prognosis is poor. Therefore, it is essential to find early diagnostic and prognostic biomarkers. DNA methylation changes play a crucial role in the process of carcinogenesis and are often investigated as promising biomarkers in many types of cancer. For analysis of DNA methylation levels of selected tumour suppressor genes in HPV-positive and HPV-negative samples (including primary tumours and corresponding metastases of metastasizing OPSCCs, primary tumours of non-metastasizing OPSCCs, and control samples), methylation-specific MLPA and methylation-specific high-resolution melting analyses were used. A significant difference in methylation between OPSCCs and the control group was observed in WT1, PAX6 (P < 0.01) and CADM1, RARβ (P < 0.05) genes. CADM1 and WT1 hypermethylation was detected mostly in HPV-positive samples; all but one HPV-negative samples were unmethylated. Moreover, hypermethylation of PAX5 gene was observed in metastases compared with control samples and was also associated with shorter overall survival of all patients (P < 0.05). Associations described herein between promoter methylation of selected genes and clinicopathological data could benefit OPSCC patients in the future by improvement in screening, early detection, and prognosis of the disease.
See more in PubMed
INTERNATIONAL AGENCY FOR RESEARCH ON CANCER . Global Cancer Observatory: GLOBOCAN 2020. 2021 Jan 5th. December, 2020. http://gco.iarc.fr/
Saba NF, Goodman M, Ward K, et al. Gender and ethnic disparities in incidence and survival of squamous cell carcinoma of the oral tongue, base of tongue, and tonsils: a surveillance, epidemiology and end results program-based analysis. Oncology. 2011;81(1):12–20. PubMed PMC
de Souza DL, Bernal MM, Jerez Roig J, et al. Oropharyngeal Cancer Survival: a Population-Based Study of Patients Diagnosed between 1978 and 2002. ISRN Oncol. 2012;39(6):207263. PubMed PMC
Osazuwa-Peters N, Adjei Boakye E, Rohde RL, et al. Understanding of risk factors for the human papillomavirus (HPV) infection based on gender and race. Sci Rep. 2019. Jan 22;9(1):297. PubMed PMC
Chaturvedi AK, Graubard BI, Broutian T, et al. Effect of Prophylactic Human Papillomavirus (HPV) Vaccination on Oral HPV Infections Among Young Adults in the United States. J Clin Oncol. 2018. 01;36(3):262–267. PubMed PMC
Chaturvedi AK, Engels EA, Pfeiffer RM, et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol. 2011. Nov;29(32):4294–4301. PubMed PMC
Castellsagué X, Alemany L, Quer M, et al. HPV Involvement in Head and Neck Cancers: comprehensive Assessment of Biomarkers in 3680 Patients. J Natl Cancer Inst. 2016. Jun;108(6):djv403. PubMed
Pai SI, Westra WH.. Molecular pathology of head and neck cancer: implications for diagnosis, prognosis, and treatment. Annu Rev Pathol. 2009;4(1):49–70. PubMed PMC
Chmelarova M, Palicka V. Epigenetics in cancer: a promising path to follow? Clin Chem Lab Med. 2019. Jun 26;57(7):927–931. PubMed
Bhat S, Kabekkodu SP, Noronha A, et al. Biological implications and therapeutic significance of DNA methylation regulated genes in cervical cancer. Biochimie. 2016Feb;121:298–311. PubMed
Westra WH, Lewis JS. Update from the 4th Edition of the World Health Organization Classification of Head and Neck Tumours: oropharynx. Head Neck Pathol. 2017. Mar;11(1):41–47. PubMed PMC
Laco J, Sieglová K, Vošmiková H, et al. The presence of high-risk human papillomavirus (HPV) E6/E7 mRNA transcripts in a subset of sinonasal carcinomas is evidence of involvement of HPV in its etiopathogenesis. Virchows Arch. 2015. Oct;467(4):405–415. PubMed
Demokan S, Dalay N. Role of DNA methylation in head and neck cancer. Clin Epigenetics. 2011. Aug;2(2):123–150. PubMed PMC
Fisser MC, Rommer A, Steinleitner K, et al. Induction of the proapoptotic tumor suppressor gene Cell Adhesion Molecule 1 by chemotherapeutic agents is repressed in therapy resistant acute myeloid leukemia. Mol Carcinog. 2015. Dec;54(12):1815–1819. PubMed
Mao X, Seidlitz E, Truant R, et al. Re-expression of TSLC1 in a non-small-cell lung cancer cell line induces apoptosis and inhibits tumor growth. Oncogene. 2004. Jul 22;23(33):5632–5642. PubMed
Chen K, Wang G, Peng L, et al. CADM1/TSLC1 inactivation by promoter hypermethylation is a frequent event in colorectal carcinogenesis and correlates with late stages of the disease. Int J Cancer. 2011. Jan 15;128(2):266–273. PubMed
Overmeer RM, Henken FE, Snijders PJ, et al. Association between dense CADM1 promoter methylation and reduced protein expression in high-grade CIN and cervical SCC. J Pathol. 2008. Aug;215(4):388–397. PubMed
Vallath S, Sage EK, Kolluri KK, et al. CADM1 inhibits squamous cell carcinoma progression by reducing STAT3 activity. Sci Rep. 2016. Apr 1;6(1):24006. PubMed PMC
Steenbergen RD, Kramer D, Braakhuis BJ, et al. TSLC1 gene silencing in cervical cancer cell lines and cervical neoplasia. J Natl Cancer Inst. 2004. Feb 18;96(4):294–305. PubMed
van Kempen PM, Noorlag R, Braunius WW, et al. Differences in methylation profiles between HPV-positive and HPV-negative oropharynx squamous cell carcinoma: a systematic review. Epigenetics. 2014. Feb;9(2):194–203. PubMed PMC
van Kempen PM, van Bockel L, Braunius WW, et al. HPV-positive oropharyngeal squamous cell carcinoma is associated with TIMP3 and CADM1 promoter hypermethylation. Cancer Med. 2014. Oct;3(5):1185–1196. PubMed PMC
Woo HJ, Kim SJ, Song KJ, et al. Hypermethylation of the tumor-suppressor cell adhesion molecule 1 in human papillomavirus-transformed cervical carcinoma cells. Int J Oncol. 2015;46(6):2656–2662. PubMed PMC
Guerrero-Preston R, Michailidi C, Marchionni L, et al. Key tumor suppressor genes inactivated by “greater promoter” methylation and somatic mutations in head and neck cancer. Epigenetics. 2014. Jul;9(7):1031–1046. PubMed PMC
Hayashi M, Guerrero-Preston R, Sidransky D, et al. Paired box 5 methylation detection by droplet digital PCR for ultra-sensitive deep surgical margins analysis of head and neck squamous cell carcinoma. Cancer Prev Res (Phila). 2015. Nov;8(11):1017–1026. PubMed PMC
Wu D, Zhang J, Fan P, et al. Methylation in the promoter regions of WT1, NKX6-1 and DBC1 genes in cervical cancer tissues of Uygur women in Xinjiang. Genet Mol Biol. 2018. Jan-Mar;41(1):9–17. PubMed PMC
Scharnhorst V, van der EAJ, Jochemsen AG. WT1 proteins: functions in growth and differentiation. Gene. 2001;273(2):141–161. 2001/08//. PubMed
Ribeiro IP, Caramelo F, Marques F, et al. WT1, MSH6, GATA5 and PAX5 as epigenetic oral squamous cell carcinoma biomarkers - a short report. Cell Oncol (Dordr). 2016. Dec;39(6):573–582. PubMed
Oji Y, Yamamoto H, Nomura M, et al. Overexpression of the Wilms’ tumor gene WT1 in colorectal adenocarcinoma. Cancer Sci. 2003. Aug;94(8):712–717. PubMed PMC
Lotan R. Retinoids in cancer chemoprevention. FASEB J. 1996. Jul;10(9):1031–1039. PubMed
McGregor F, Muntoni A, Fleming J, et al. Molecular Changes Associated with Oral Dysplasia Progression and Acquisition of Immortality: Potential for Its Reversal by 5-Azacytidine. Cancer Res . 2002;62(16): 4757–4766. PubMed
Maruya S, Issa JP, Weber RS, et al. Differential methylation status of tumor-associated genes in head and neck squamous carcinoma: incidence and potential implications. Clin Cancer Res. 2004. Jun;10(11):3825–3830. PubMed
Youssef EM, Lotan D, Issa JP, et al. Hypermethylation of the retinoic acid receptor-beta(2) gene in head and neck carcinogenesis. Clin Cancer Res. 2004. Mar;10(5):1733–1742. PubMed
Zhang X, Yang X, Wang J, et al. Down-regulation of PAX6 by promoter methylation is associated with poor prognosis in non small cell lung cancer. Int J Clin Exp Pathol. 2015;8(9):11452–11457. PubMed PMC